-
1
-
-
84899618667
-
Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment
-
1400–9
-
Zhang Y, Yu X, Ichikawa M, et al. Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol. 2014; 133(5):1400–9, 9.e1–5.
-
(2014)
J Allergy Clin Immunol
, vol.133
, Issue.5
, pp. 1-5
-
-
Zhang, Y.1
Yu, X.2
Ichikawa, M.3
-
2
-
-
84904036824
-
PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia
-
Stray-Pedersen A, Backe PH, Sorte HS, et al. PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia. Am J Hum Genet. 2014; 95(1):96–107.
-
(2014)
Am J Hum Genet
, vol.95
, Issue.1
, pp. 96-107
-
-
Stray-Pedersen, A.1
Backe, P.H.2
Sorte, H.S.3
-
3
-
-
0036521070
-
Identification of human phosphoglucomutase 3 (PGM3) as N-acetylglucosamine-phosphate mutase (AGM1)
-
Pang H, Koda Y, Soejima M, Kimura H. Identification of human phosphoglucomutase 3 (PGM3) as N-acetylglucosamine-phosphate mutase (AGM1). Ann Hum Genet. 2002; 66(Pt 2):139–44.
-
(2002)
Ann Hum Genet
, vol.66
, pp. 139-144
-
-
Pang, H.1
Koda, Y.2
Soejima, M.3
Kimura, H.4
-
4
-
-
84899629014
-
Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels
-
1410–9
-
Sassi A, Lazaroski S, Wu G, et al. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. J Allergy Clin Immunol. 2014; 133(5):1410–9, 9.e1–13.
-
(2014)
J Allergy Clin Immunol
, vol.133
, Issue.5
, pp. 1-13
-
-
Sassi, A.1
Lazaroski, S.2
Wu, G.3
-
5
-
-
0016675566
-
The linkage relationships of HL-A with other genetic marker systems
-
Weitkamp LR, May AG, Johnston E. The linkage relationships of HL-A with other genetic marker systems. Hum Hered. 1975; 25(5):337–45.
-
(1975)
Hum Hered
, vol.25
, Issue.5
, pp. 337-345
-
-
Weitkamp, L.R.1
May, A.G.2
Johnston, E.3
-
6
-
-
34547913040
-
Agm1/Pgm3-mediated sugar nucleotide synthesis is essential for hematopoiesis and development
-
Greig KT, Antonchuk J, Metcalf D, et al. Agm1/Pgm3-mediated sugar nucleotide synthesis is essential for hematopoiesis and development. Mol Cell Biol 2007; 27(16):5849–59.
-
(2007)
Mol Cell Biol
, vol.27
, Issue.16
, pp. 5849-5859
-
-
Greig, K.T.1
Antonchuk, J.2
Metcalf, D.3
-
7
-
-
1442357480
-
Familial immunodeficiency with cutaneous vasculitis, myoclonus, and cognitive impairment
-
Hay BN, Martin JE, Karp B, et al. Familial immunodeficiency with cutaneous vasculitis, myoclonus, and cognitive impairment. Am J Med Genet A. 2004;125a(2):145–51.
-
(2004)
Am J Med Genet A
, vol.125
, Issue.2
, pp. 145-151
-
-
Hay, B.N.1
Martin, J.E.2
Karp, B.3
-
8
-
-
84945280026
-
Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 (PGM3) gene
-
Lundin KE, Hamasy A, Backe PH, et al. Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 (PGM3) gene. Clin Immunol. 2015; 161(2):366–72.
-
(2015)
Clin Immunol
, vol.161
, Issue.2
, pp. 366-372
-
-
Lundin, K.E.1
Hamasy, A.2
Backe, P.H.3
-
9
-
-
84953636114
-
Neonatal-onset T(-)B(-)NK(+) severe combined immunodeficiency and neutropenia caused by mutated phosphoglucomutase 3
-
Bernth-Jensen JM, Holm M, Christiansen M. Neonatal-onset T(-)B(-)NK(+) severe combined immunodeficiency and neutropenia caused by mutated phosphoglucomutase 3. J Allergy Clin Immunol. 2016; 137(1):321–4.
-
(2016)
J Allergy Clin Immunol
, vol.137
, Issue.1
, pp. 321-324
-
-
Bernth-Jensen, J.M.1
Holm, M.2
Christiansen, M.3
-
10
-
-
84904876386
-
Transplantation outcomes for severe combined immunodeficiency, 2000–2009
-
Pai SY, Logan BR, Griffith LM, et al. Transplantation outcomes for severe combined immunodeficiency, 2000–2009. N Engl J Med. 2014; 371(5):434–46.
-
(2014)
N Engl J Med
, vol.371
, Issue.5
, pp. 434-446
-
-
Pai, S.Y.1
Logan, B.R.2
Griffith, L.M.3
-
11
-
-
34247122497
-
The impact of glycosylation on the biological function and structure of human immunoglobulins
-
Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol. 2007; 25:21–50.
-
(2007)
Annu Rev Immunol
, vol.25
, pp. 21-50
-
-
Arnold, J.N.1
Wormald, M.R.2
Sim, R.B.3
Rudd, P.M.4
Dwek, R.A.5
-
13
-
-
0035716899
-
Update and perspectives on congenital disorders of glycosylation
-
Freeze HH. Update and perspectives on congenital disorders of glycosylation. Glycobiology. 2001; 11(12):129r–43r.
-
(2001)
Glycobiology
, vol.11
, Issue.12
, pp. 43r-129r
-
-
Freeze, H.H.1
-
14
-
-
0042266719
-
A genetic approach to Mammalian glycan function
-
Lowe JB, Marth JD. A genetic approach to Mammalian glycan function. Annu Rev Biochem. 2003; 72:643–91.
-
(2003)
Annu Rev Biochem
, vol.72
, pp. 643-691
-
-
Lowe, J.B.1
Marth, J.D.2
|